Bio-Rad Laboratories, Inc.
Bio‑Rad Laboratories, Inc. (BIO) designs and sells instruments, reagents and software for life‑science research and clinical diagnostics. The business is organised mainly into two segments: Life Science, which serves academic and industrial researchers, and Clinical Diagnostics, which supplies hospitals and clinical laboratories. Revenue benefits from recurring consumables and service contracts alongside new equipment sales, giving a mix of predictable and cyclical income. The company invests in R&D and occasionally grows through acquisitions, with global distribution and an installed base that supports aftermarket demand. Key risks include regulatory approvals, reimbursement dynamics in diagnostics, competition, foreign‑exchange exposure and potential execution risks from integration or capital projects. Market cap is roughly $8.9bn. This summary is for educational purposes only and not personalised investment advice; investments can fall as well as rise and you should consider your own circumstances or consult a financial adviser.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Bio-Rad's stock with a target price of $366.2, indicating strong growth potential.
Financial Health
Bio-Rad Laboratories shows strong revenue and cash flow, indicating solid financial performance and stability.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring BIO
Activist Sparks Life Science Shakeup
Activist investor Engine Capital is pushing for a sale of life-sciences company Avantor after taking a significant stake. This move could spark a wave of M&A across the life-sciences supply industry, creating opportunities for competitor firms and other potential acquisition targets.
Published: August 11, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Recurring Consumables Appeal
A significant portion of revenue comes from consumables and service contracts, which can provide steady cash flow — though demand can fluctuate with research funding and testing volumes.
Global Customer Base
Sales span academic research, biotech and clinical labs worldwide, offering diversification across markets, but international exposure brings currency and regulatory risks.
R&D and Innovation
Continued investment in R&D and selective acquisitions can drive new product cycles, yet execution and integration risk mean outcomes are not assured.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Abbott Laboratories
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
Agilent Technologies Inc.
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. The Life Sciences and Diagnostics Markets segment provides contract development and manufacturing services for pharmaceutical customers as well as solutions that include reagents, instruments, software and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab segment spans the entire lab with its services and consumables portfolio in addition to software and laboratory automation solutions, which are designed to improve customer outcomes and represent a range of offerings designed to serve customer needs across end-markets and applications.
Align Technology Inc.
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
